Now that COVID-19 vaccines are being rolled out, policymakers are wrestling with the question of how to distribute…
OnDecember11,2020, theUSFoodandDrugAdministration(FDA) issued an Emergency Use Authorization (EUA) for the Pfizer- BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered…
In this small study involving older adults, adverse events associated with the mRNA-1273 vaccine were mainly mild or…
Antigens displayed on self-assembling nanoparticles can stimulate strong immune responses and have been playing an increasingly prominent role…
SARS-CoV-2 spike probes are key to antibody discovery and vaccineevaluation. By using structure-based design, affinity purification, on-column biotinylation,…
SARS-CoV-2 poses a public health threat for which therapeutic agents are urgently needed. Herein, we report that high-throughput…
The safety and immunogenicity data from this U.S. phase 1 trial of two vaccine candidates in younger and…
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older.…
The distribution of target groups at country and regional levels highlights the importance of designing an equitable and…
Early in the covid-19 pandemic it was unclear whether and how individuals and populations would develop protective and…
The Indian manufacturer of the Oxford-AstraZeneca candidate vaccine against covid-19 (the Serum Institute of India) has threatened to…
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 1 million deaths in…
The global effort to develop a coronavirus disease 2019 (COVID-19) vaccine is likely to soon produce one or…
Worldwide, leaders are implementing non-pharmaceutical interventions to slow transmission of the novel coronavirus while pursuing vaccines that confer…
At present, no cure is available for COVID-19 but vaccines, antiviral drugs, immunoglobulins, or the combination of immunoglobulins…
Vaccinations are effective in preventing infections; however, it is unknown if patients with chronic lymphocytic leukemia (CLL) who…
Coronavirus disease 2019 (COVID‑19) is an acute pneumonic disease, with no prophylactic or specific therapeutical solution. Effective and…
As COVID-19 is new to humankind and the nature of protective immune responses is poorly understood, it is…
In this review, we showcase the similarities in structures of virus components between SARS-CoV, MERS-CoV, and SARS-CoV-2 in…
Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older…